What is a Diabetic Foot Infection?
A diabetic foot infection (DFI) is a clinically diagnosed condition defined as the invasion and multiplication of microorganisms in soft tissue or bone anywhere below the malleoli in a person with diabetes, manifesting as local (and occasionally systemic) signs and symptoms of inflammation. 1
Pathophysiology and Development
DFIs typically begin with a break in the protective skin envelope, most commonly through a foot ulcer that develops due to peripheral neuropathy 2, 1. The infection pathway follows this sequence:
- Skin trauma or ulceration occurs (usually from repetitive stress, foot deformities, or unnoticed injury due to loss of protective sensation)
- The wound becomes colonized with microorganisms (typically skin flora)
- In many cases, colonization progresses to true infection with tissue invasion and inflammatory response
- Infection can spread contiguously to subcutaneous tissues, muscle, joints, and bone 1
Key predisposing factors include 2, 1:
- Peripheral neuropathy (sensory, motor, and autonomic) - the primary factor
- Peripheral arterial disease - increases infection risk and worsens outcomes
- Foot ulceration that is deep, long-standing, recurrent, or traumatic
- Diabetes-related immune dysfunction
- Chronic renal failure
Clinical Diagnosis
Infection must be diagnosed clinically based on the presence of ≥2 classic findings of inflammation or purulence 2, 3. Laboratory and microbiological investigations have limited diagnostic utility except for osteomyelitis 2.
Primary signs of infection include:
- Redness
- Warmth
- Swelling
- Pain or tenderness
- Purulent secretions
Secondary findings that raise suspicion 4:
- Non-purulent secretions
- Friable or discolored granulation tissue
- Wound undermining
- Foul odor
Important caveat: Signs of inflammation may be masked by peripheral neuropathy, ischemia, or immune dysfunction, making diagnosis challenging 5.
Microbiology
Aerobic gram-positive cocci, especially Staphylococcus aureus, are the predominant pathogens 2. However, the microbiology varies by clinical context:
- Acute, previously untreated infections: Primarily gram-positive cocci (staphylococci and streptococci)
- Chronic or previously treated wounds: Often polymicrobial with gram-negative rods
- Ischemic or gangrenous wounds: May include obligate anaerobes 2
Severity Classification
Infections should be categorized by severity based on:
- Specific tissues involved
- Adequacy of arterial perfusion
- Presence of systemic toxicity or metabolic instability 2
The IWGDF/IDSA classification stratifies infections as:
- Mild: Superficial, limited in size and depth
- Moderate: Deeper or more extensive
- Severe: Accompanied by systemic inflammatory response signs or metabolic perturbations 5, 3
Clinical Significance and Outcomes
DFIs represent a major cause of morbidity and mortality 2, 1:
- Most frequent diabetic complication requiring hospitalization
- Most common precipitating event leading to lower extremity amputation
- Infection plays a role in approximately 60% of diabetes-related amputations 6
- Associated with substantial healthcare costs and reduced quality of life
Osteomyelitis is a particularly serious complication that:
- Occurs in many patients with foot wounds
- Dramatically increases amputation risk
- Requires prolonged antibiotic therapy and often surgical intervention 2, 3
Management Principles
DFIs require coordinated multidisciplinary management preferably by a foot-care team that includes infectious disease specialists 2, 5. Key management components include:
- Clinical diagnosis and severity assessment
- Appropriate microbiological sampling (tissue specimens preferred over swabs) 2, 1
- Empiric antibiotic therapy tailored to severity
- Surgical debridement when indicated
- Vascular assessment and revascularization if needed
- Proper wound care and pressure off-loading
- Metabolic control (especially hyperglycemia)
Critical distinction: Not all diabetic foot wounds are infected—wounds without evidence of soft tissue or bone infection do not require antibiotic therapy 7, 8, 3.